Recent News

Read articles relating to the research and clinical trial below.


New Curtin research identifies likely cause of Alzheimer’s disease

Ground-breaking new Curtin University-led research has discovered a likely cause of Alzheimer’s disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia’s second-leading cause of death.


Curtin Alzheimer's research project awarded NHMRC funding

New opportunities for the prevention and treatment of Alzheimer’s Disease will be further explored at Curtin-CHIRI, with our Director, Professor John Mamo, and his team receiving a $637K Ideas Grant from the National Health and Medical Research Council (NHMRC). Announced by Federal Health Minister Greg Hunt, the support will enable the team to further explore a remarkable discovery they have made in this area of research.


A research collaboration led by Curtin Health Innovation Research Institute (CHIRI) Director Professor John Mamo will get to trial a new treatment for the most common form of Alzheimer’s disease with the announcement of $1.72 million in Federal Government funding to Curtin University.


A $150,000 donation from MSWA will enable a research team at Curtin University led by CHIRI Director Professor John Mamo to embark on a pilot clinical trial of a drug that aims to prevent further memory loss in people living with Alzheimer’s disease. 


Media and Scientific Enquiries

If you would like to speak with our research team about the PIA-Study, please contact Professor John Mamo via the contact options below